The PD group showed decreased expression of mGluR2 and mGluR3, whereas the PD + Ex group showed increased expression of these proteins in the presynaptic terminals of the glutamatergic neurons, thereby limiting Glu release into the synaptic cleft (Chen and Li, 2019; Shi et al., 2019). The gene discussed is GRM3; the disease is Parkinson disease.